References
- MuñozRFLenertLLDelucchiKToward evidence based internet interventios: a Spanish/English Web site for international smoking cessation trialsNicotine Tob Res200681778716497602
- ThunMJApicallaLFHenleySJSmoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroomJAMA20002841870671210927778
- World Health OrganizationTobacco or Health: A Global Status ReportGeneva, SwitzerlandWorld Health Organization1997
- BlackfordALYangGHernandez-AvilaMCotinine concentration in smokers from different countries: relationship with amount smoked and cigarette typeCancer Epidemiol Biomarkers Prev200615101799180417021350
- SussmanSDentCWFive-year prospective prediction of self-initiated quitting of cigarette smoking of high-risk youthAddict Behav20073251094109816876332
- SussmanSEffects of sixty-six adolescent tobacco use cessation trials and seventeen prospective studies of self-initiated quittingTobInd Dis2002113581
- US. Department of Health and Human ServicesPreventing tobacco use among young people: A report of the surgeon generalRockville, MDPublic Health Service1994
- US. Department of Health and Human ServicesReducing tobacco use: A report of the surgeon generalAtlanta, GAOffice on Smoking and Health2000
- PandaySReddySPRuiterRACBergströmEde VriesHNicotine dependence and withdrawal symptoms among occasional smokersJ Adolesc Health200740214415017259054
- EldersMJPerryCLEriksenMPGiovinoGThe report of the Surgeon General: preventing tobacco use among young peopleAm J Public Health19948445435478154552
- PetoRLopezADBorehamJMortality from smoking in developed countries 1950–2000Oxford, UKOxford University Press2004
- DollRPetoRBorehamJMortality in relation to smoking: 50 years’ observations on male British doctorsBMJ2004328150715217842
- US. Department of Health and Human ServicesThe Health Benefits of Smoking CessationWashington, DC, USGovernment Printing Office1990
- US Department of Health and Human ServicesThe Health Consequences of Smoking: Nicotine AddictionWashington, DC, USGovernmentPrinting Office1988
- Royal College of PhysiciansNicotine Addiction in Britain: A Report of the Tobacco Advisory Group of the Royal College of PhysiciansLondonRoyal College of Physicians2000
- FouldsJBurkeMSteinbergMWilliamsJMZiedonisDMAdvances in pharmacotherapy for tobacco dependenceExpert OpinEmerg Drugs2004913953
- BenowitzNLDrug therapy. Pharmacologic aspects of cigarette smoking and nicotine addictionN Engl J Med198831920131813303054551
- SchererGSmoking behavior and compensation: a review of the literaturePsychopharmacology (Berl)1999145112010445368
- BalfourDJThe neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbensNicotine Tob Res20046689991215801566
- GarretBERoseCAHennigfieldJETobacco addiction and pharmacological interventionsExpert Opin Pharmacother20012101545155511825298
- SteadLPereraRBullenCMantDLancasterTNicotine replacement therapy for smoking cessationCochrane Database Syst Rev20081CD00014618253970
- FrishmanWHMittaWKupersmithAKyTNicotine and non-nicotine smoking cessation pharmacotherapiesCardiol Rev2006142577316493243
- HenningfieldJEFantRVBuchhalterARStitzerMLPharmacotherapy for nicotine dependenceCancer J Clin20055528199
- Tobacco Advisory Group of the Royal College of PhysiciansIs nicotine a drug of addiction? Nicotine addiction in BritainLondonRoyal College of Physicians of London2000
- GiovinoGAHenningfieldJETomarSLEscobedoLGSladeJEpidemiology of tobacco use and dependenceEpidemiol Rev19951748658521946
- BenowitzNLNicotine addictionPrim Care199926611639922291
- US. Department of Health and Human ServicesThe health consequences of smoking: nicotine addictionRockville, MDOffice on Smoking and Health1988
- Centers for Disease ControlCigarette smoking among adults-United StatesMMWR Morb Mortal Wkly Rep2001504086987311666113
- Trends in cigarette smoking among high school students-United States, 1991–2001MMWR Morb Mortal Wkly Rep2002511940941212033476
- PallonenUEProchaskaJOVelicerWFStages of acquisition and cessation for adolescent smoking: an empirical integrationAddict Behav19982333033249668929
- ProkhorovAVHudmonKSde MoorCANicotine dependence, withdrawal symptoms, and adolescents’ readiness to quit smokingNicotine Tob Res20013215115511403729
- HenningfieldJEKeenanRMNicotine delivery kinetics and abuse liabilityJ Consult Clin Psychol1993617437508245272
- MaesHHSullivanPFBulikCMA twin study of genetic and environmental influences in tobacco initiation, regular tobacco use and nicotine dependencePsychol Med20043471251126115697051
- TashkinDPMurrayRPSmoking cessation in chronic obstructive pulmonarydiseaseRespiratory Med20091037963974
- DominoENiLXuYKoeppeRAGuthrieSZubietaJKRegional cerebral blood flow and plasma nicotine after smoking tobacco cigarettesProg Neuropsychopharmacol Biol Psychiatry200428231932714751429
- GoldingJFProsyanikovaOFlynnMGrestyMAThe effect of smoking nicotine tobacco versus smoking deprivation on motion sicknessAuton Neurosci20111601–2535821036110
- LevinEDMcClernonFJRezvaniAHNicotinic effects on cognitive function: behavioral characterization, pharmacological specification and anatomic localizationPsychopharmacology (Berl)20061843–452353916220335
- RoseJECorrigallWANicotine self-administration in animals and humans: similarities and differencesPsychopharmacology (Berl)19971301128409089846
- ZacnyJPStitzerMLCigarette brand-switching: effects on smoke exposure and smoking behaviorJ Pharmacol Exp Ther198824626196273404450
- BrewerBRobertsARowellPShort-term distribution of nicotine in the rat lungDrug Alcohol Depend200475219319815276225
- YildizDNicotine, its metabolism and an overview of its biological effectsToxicon200443661963215109883
- DomePLazaryJKalaposMZoltanRihmerSmoking, nicotine and neuropsychiatric disordersNeurosci Biobehav Rev2010349329534219665479
- MetzCNGregersenPKMalhotraAKMetabolism and biochemical effects of nicotine for primary care providersMed Clin North Am20048861399141315464104
- BakerRMasseyESmithGAn overview of the effects of tobacco ingredients on smoke chemistry and toxicityFood Chem Toxicol200442SupplS53S8315072838
- JonesSSudweeksSYakelJLNicotinic receptors in the brain: correlating physiology with functionTrends Neurosci1999221255556110542436
- LevinEDThe role of nicotinic acetylcholine receptors in cognitive functionClementiFGottiCFornasariDHandbook of experimental pharmacology: neuronal nicotinic receptorsNew YorkSpringer-Verlag2000587602
- LevinEDRezvaniAHDevelopment of nicotinic drug therapy for cognitive disordersEur J Pharmacol20003931–314114610771007
- LevinEDSimonBBNicotinic acetylcholine involvement in cognitive function in animalsPsychopharmacology (Berl)19981383–42172309725745
- PicciottoMRNicotine as a modulator of behavior: beyond the inverted UTrends Pharmacol Sci20032449349912967775
- LevinEDBencanZCeruttiDTAnxiolytic effects of nicotine in ZebrafishPhysiolBehav20079015458
- PicciottoMRCaldaroneBJKingSLZachariouVNicotinic receptors in the brain: Links between molecular biology and behaviorNeuropsychopharmacology200022545146510731620
- WooltortonJRPidoplichkoVIBroideRSDaniJADifferential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areasJ Neurosci20032383176318512716925
- LeonardSBertrandDNeuronal nicotinic receptors: from structure to functionNicotine Tob Res20013320322311506765
- ZoliMMorettiMZanardiAMcIntoshJMClementtiFGottiCIdentification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatumJ Neurosci200222208785878912388584
- MansvelderHDMcGeheeDSCellular and synaptic mechanisms of nicotine addictionJ Neurobiol200253460661712436424
- MarshallDLRedfernPHWonnacottSPresynaptic nicotinic modulation of dopamine release in the three ascending pathways studied byin vivomicrodialysis: comparison of naive and chronic nicotinetreated animalsJ Neurochem1997684151115199084421
- BakerRRMasseyEDSmithGAn overview of the effects of tobacco ingredients on smoke chemistry and toxicityFood Chem Toxicol200442SupplS53S8315072838
- NewhousePPotterASinghAEffects of nicotinic stimulation on cognitive performanceCurr Opin Pharmacol200441364615018837
- CaiJLiuBLinPSuQFast analysis of nicotine related alkaloids in tobacco and cigarette smoke by megabore capillary gas chromatographyJ Chromatog A200310171–218719314584703
- EisenbergMJFilionKBYavinDPharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trialsCMAJ2008179213514418625984
- FioreMCJaénCRBakerTBfor Rockville Md: US Dept of Health and Human ServicesTreating tobacco use and dependence: 2008 Update. Clinical Practice GuidelinePublic Health Service2008
- LermanCKaufmannVRukstalisMIndividualizing nicotine replacement therapy for the treatment of tobacco dependence: A randomized trialAnn Intern Med2004140642643315023708
- SilagyCLancasterTSteadLMantDFowlerGNicotine replacement therapy for smoking cessation [Update appears in Cochrane Database Syst Rev 2004;3:CD000146]Cochrane Database Syst Rev20024CD00014612519537
- SutherlandGStapletonJARussellMARandomised controlled trial of nasal nicotine spray in smoking cessationLancet199234088153243291353803
- Escobar-ChávezJJMerinoVLópez-CervantesMRodríguez-CruzIMQuintanar-GuerreroDGanem-QuintanarAThe use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessationCurr Drug Discov Technol20096317118519496753
- HenselMRCavanaghTLanierAPQuit rates at one year followup of Alaska Native Medical Center Tobacco Cessation ProgramAlaska Med199537243477661325
- CartonSLe HouezecJLagrueGJouventRRelationships between sensation seeking and emotional symptomatology during smoking cessation with nicotine patch therapyAddict Behav200025565366211023009
- ShiffmanSDreslerCMHajekPGilburtSJTargettDAStrahsKREfficacy of a nicotine lozenge for smoking cessationArch Intern Med20021621267127612038945
- ShiffmanSDreslerCMRohayJMSuccessful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy [Published correction appears in Addiction 2004;99:273]Addiction2004991839214678066
- NielsenKFioreMCCost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessationPrev Med200030320921610684744
- BenowitzNLDrug therapy. Pharmacologic aspects of cigarette smoking and nicotine addictionN Engl Med19883192013181330
- HughesJRGustSWKeenanRFenwickJWSkoogKHigginsSTLongterm use of nicotine vs placebo gumArch Intern Med199115110199319981929687
- KornitzerMBoutsenMDramaixMThijsJGustavssonGCombined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trialPrev Med199524141477740014
- BlondalTGudmundssonLJOlafsdottirIGustavssonGWestinANicotine nasal spray with nicotine patch for smoking cessation: randomized trial with six year follow up [Published correction appears in BMJ. 1999;318:764]BMJ19993182852889924052
- BohadanaANilssonFRasmussenTMartinetYNicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trialArch Intern Med20001603128313411074742
- WebbMSde YbarraRDBakerEAReisIMCareyMPCognitive–behavioral therapy to promote smoking cessation among African American smokers: a randomized clinical trialJ Consult Clin Psychol2010781243320099947
- AlbergAJStashefskyMargalitRBurkeAThe influence of offering free transdermal nicotine patches on quit rates in a local health department’s smoking cessation programAddict Behav20042991763177815530720
- NidesMOnckenCGonzalesDSmoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: Results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-upArch Intern Med2006166151561156816908788
- OnckenCGonzalesDNidesMEfficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessationArch Intern Med2006166151571157716908789
- NiauraRHaysJTJorenbyDEThe efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trialCurr Med Res Opin20082471931194118513462
- TsaiSTChoHJChengHSA randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokersClin Ther20072961027103917692719
- NakamuraMOshimaAFujimotoYMaruyamaNIshibashiTReevesKREfficacy and tolerability of varenicline, an alpha4-beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokersClin Ther20072961040105617692720
- TonstadSTønnesenPHajekPWilliamsKEBillingCBReevesKRfor the Varenicline Phase 3 Study GroupEffect of maintenance therapy with vareniciine on smoking cessation: a randomized controlled trialJAMA20062961647116820548
- WilliamsKEReevesKRBillingCBPenningtonAMGongJA double-blind study evaluating the long-term safety of varenicline for smoking cessationCurr Med Res Opin200723479380117407636
- Daubney GarrisonGDuganSEVarenicline: a first-line treatment option for smoking cessationClin Ther200931346349119393839
- AhluwaliaJSHarrisKJCatleyDOkuyemiKSMayoMSSustained-release bupropion for smoking cessation in African Americans: a randomized controlled trialJAMA2002288446847412132977
- JorenbyDELeischowSJNidesMAA controlled trial of sustained release bupropion, a nicotine patch, or both for smoking cessationN Engl J Med1999340968569110053177
- HurtRDSachsDPGloverEDA comparison of sustained release bupropion and placebo for smoking cessationN Engl J Med199733717119512029337378
- BreslauNKilbeyMAndreskiPNicotine dependence, major depression, and anxiety in young adultsArch Gen Psychiatry19914812106910741845224
- RichmondRZwarNReview of bupropion for smoking cessationDrug Alcohol Rev200322220322012850907
- ParsonsACShraimMInglisJAveyardPHajekPInterventions for preventing weight gain after smoking cessationCochrane Database Syst Rev20091CD00621919160269
- HallSMReusVIMunozRFNortriptyline and cognitive behavioral therapy in the treatment of cigarette smokingArch Gen Psychiatry19985586836909707377
- ProchazkaAVWeaverMJKellerRTFryerGELicariPALofasoDA randomized trial of nortriptyline for smoking cessationArch Intern Med199815818203520399778204
- HallSMHumfleetGLReusVIMunozRFHartzDTMaude-GriffinRPsychological intervention and antidepressant treatment in smoking cessationArch Gen Psychiatry2002591093093612365880
- Da CostaCLYounesRNLourencoMTStopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placeboChest2002122240340812171809
- HughesJRSteadLFLancasterTNortriptyline for smoking cessation: a reviewNicotine Tob Res20057449149916085520
- CoveyLSGlassmanAHA meta-analysis of double-blind placebo controlled trials of clonidine for smoking cessationBr J Addict19918689919981833003
- GourlaySGBenowitzNIs clonidine an effective smoking cessation therapy?Drugs19955021972078521754
- GourlaySGSteadLFBenowitzNLClonidine for smoking cessationThe Cochrane Library3Chichester, UKJohn Wiley & Sons, Ltd2000
- DavidSLancasterTSteadLFEvinsAEOpioid antagonists for smoking cessationCochrane Database Syst Rev20064CD00308617054160
- TollBAWhiteMWuRLow-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: A randomized trialDrug Alcohol Depend2010111320020620542391
- TollBALearyVWuRSaloveyPMeandzijaBO’MalleySSA preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gainAddict Behav200833117317917587504
- GreenwayFLDunayevichETollefsonGfor the NB-201 Study GroupComparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and PlaceboJ Clin Endocrinol Metab200994124898490619846734
- WilcoxCSOskooilarNEricksonJSAn open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjectsAddict Behav201035322923419926400
- HughesJRSteadLFLancasterTAntidepressants for smoking cessation (Cochrane Review)The Cochrane Library4Chichester, UKJohn Wiley & Sons, Ltd2004
- HitsmanBPingitoreRSpringBAntidepressant pharmacotherapy helps some cigarette smokers more than othersJ Consult Clin Psychol199967454755410450625
- SchneiderNGOlmsteadRESteinbergCSloanKDaimsRMBrownHBEfficacy of buspirone in smoking cessation: a placebo controlled trialClin Pharmacol Ther19966055685758941030
- HughesJRSteadLFLancasterTAnxiolytics and antidepressants for smoking cessation (Cochrane Review)The Cochrane Library4Chichester, UKJohn Wiley & Sons, Ltd2000
- LancasterTSteadLFMecamylamine (a nicotine antagonist) for smoking cessationThe Cochrane Library2Chichester, UKJohn Wiley and Sons, Ltd1998
- GronierBRasmussenKActivation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivoelectrophysiological study in the ratBr J Pharmacol1998124345544564
- McKeeSAWeinbergerAHHarrisonELRCoppolaSGeorgeTPEffects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: A preliminary studySchizophr Res20091152–331732419700263
- GeorgeTPWeinbergerAHMonoamine oxidase inhibition for tobacco pharmacotherapyClin Pharmacol Ther200883461962118091758
- BerlinISaidSSpreux-VaroquauxOA reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokersClin Pharmacol Ther19955844444527586937
- HiedaYKeylerDEVandevoortJTActive immunization alters the plasma nicotine concentration in ratsJ Pharmacol Exp Ther19972833107610819399979
- De VilliersSHLindblomNKalayanovGActive immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shellRespiration200269324725312097769
- CarreraMRAshleyJAHoffmanTZInvestigations using immunization to attenuate the psychoactive effects of nicotineBioorg Med Chem200412356357014738965
- SandersonSDCherukuSRPadmanilayamMPImmunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvantInt Immunopharmacol20033113714612538044
- CernyEHLevyRMauelJPreclinical development of a vaccine “against smoking”Onkologie200225540641112415193
- PentelPRMalinDHEnnifarSA nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in ratsPharmacol Biochem Behav20006519119810638653
- MaurerPJenningsGTWillersJA therapeutic vaccine for nicotine dependence: Preclinical efficacy, and Phase I safety and immunogenicityEur J Immunol20053572031204015971275
- LeSageMGKeylerDEHiedaYEffects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine selfadministration in ratsPsychopharmacology (Berl)20061843–440941615991003
- MeijlerMMMatsushitaMAltobellLWirschingPJandaKDA new strategy for improved nicotine vaccines using conformationally constrained haptensJ Am Chem Soc2003125247164716512797775
- St Clair RobertsJAkersCVRVanhinsberghLMcKennaKWoodDMJackLLongitudinal safety and immunogenicity data of TA-NIC, a novel nicotine vaccineProceedings of the Ninth Annual Meeting of the Society for Research on Nicotine and TobaccoFebruary 19–22, 2003New Orleans, LAMiddletown, WISociety for Research on Nicotine and Tobacco2003
- HatsukamiDRennardSJorenbyDESafety and immunogenicity of nicotine conjugate vaccine in current smokersClin Pharmacol Ther200578545646716321612
- KeylerDERoikoSABenlhabibEMonoclonal nicotine specific antibodies reduce nicotine distribution to brain in rats: dose and affinity-response relationshipsDrug Metab Dispos20053371056106115843487
- MaurerPJenningsGTWillersJA therapeutic vaccine for nicotine dependence: Preclinical efficacy, and phase I safety and ImmunogenicityEur J Immunol20053572031204015971275
- SiuECTyndaleRFNon-nicotinic therapies for smoking cessationAnnu Rev Pharmacol Toxicol20074754156417209799
- HiedaYKeylerDEEnnifarSFattomAPentelPRVaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brainInt J Immunopharmacol2000221080981910963853
- DeGrandaOriveJIWhen will the nicotine vaccine be ready?Arch Bronconeumol20054112415676128
- CernyTAnti-nicotine vaccination: where are we?Recent Results-Cancer Res200516616717515648190
- CornuzJKlinglerKMuellerPA therapeutic vaccine for nicotine dependence: results of a phase I and a randomized phase II studyPresented at: American Society of Clinical OncologyMay 2005Orlando, FL Available at: http://www.asco.org/ac/1,1003,_12-002643-00_18-0034-00_19-0033424,00.asp. Accessed June 16, 2005.
- MaurerPBachmannMFVaccination against nicotine: an emerging therapy for tobacco dependenceExpert Opinion Investig Drugs2007161117751783
- HeadingCEDrug evaluation: CYT-002-NicQb, a therapeutic vaccine for the treatment of nicotine addictionCurr Opin Investig Drugs2007817177
- MaurerPBachmannMFTherapeutic vaccines for nicotine dependenceCurr Opin Mol Ther20068111616506520
- MaurerPJenningsGTWillersJA therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicityEur J Immunol20053572031204015971275
- CornuzJZwahlenSJungiWFA vaccine against nicotine for smoking cessation: a randomized controlled trialPLoS One200836e254718575629
- Trial watch: Xenova’s TA-NIC vaccine shows promiseExpert Rev Vaccines200434386
- GoniewiczMLKoszowskiBCzogalaJZymelkaANew prospects of nicotine dependence treatment – vaccinesPrzeg Lek20066311141118
- HeadingCETA-CD. XenovaIDrugs20025111070107412800060
- KostenTRRosenMBondJHuman therapeutic cocaine vaccine: Safety and immunogenicityVaccine2002207–81196120411803082
- MartellBAMitchellEPolingJGonsaiKKostenTRVaccine pharmacotherapy for the treatment of cocaine dependenceBiol Psychiatry200558215816416038686
- HeadingCENicVAX (Nabi Biopharmaceuticals)IDrugs2003611178118114666429
- KeylerDERoikoSAEarleyCAMurtaughMPPentelPREnhanced immunogenicity of a bivalent nicotine vaccineInt Immunopharmacol20088111589159418656557
- MeijlerMMMatsushitaMAltobellLJWirschingPJandaKDA new strategy for improved nicotine vaccines using conformationally constrained haptensJ Am Chem Soc2003125247164716512797775
- Clinical trials: NicVAX (Nicotine Conjugate Vaccine) Nabi Biopharmaceuticals website. Available at: http://www.nabi.com/pipeline/pipeline.php?id=3. Accessed on.
- DickersonTJYamamotoNJandaKDAntibody-catalyzed oxidative degradation of nicotine using riboflavinBioorg Med Chem200412184981498715336277
- LindblomNde VilliersSHKalayanovGGordonSJohanssonAMSvenssonTHActive immunization against nicotine prevents reinstatement of nicotine-seeking behavior in ratsRespiration200269325426012097770
- CernyEHLevyRMauelJPreclinical development of a vaccine ‘against smoking’Onkologie200225540641112415193
- HasmanAHolmSNicotine conjugate vaccine: Is there a right to a smoking future?J Med Ethics200430434434515289514
- CernyTCernyEHReply to: Hasman A and Holm S. Nicotine conjugate vaccine: Is there a right to a smoking future?J Med Ethics200531955816131563